The Bi-Specific MAbS market size is expected to reach $21.83 billion in 2030 at a CAGR of 13.5%, driven by rising prevalence of cancer and chronic diseases.
Read More
The Bisoprolol market size is expected to reach $3.26 billion in 2030 at a CAGR of 8.5%, driven by increasing prevalence of hypertension worldwide.
Read More
The Bismuth Subsalicylate market size is expected to reach $2.47 billion in 2030 at a CAGR of 6.5%, driven by growing prevalence of gastrointestinal disorders.
Read More
The Bipolar Disorder Drugs And Treatment market size is expected to reach $10.83 billion in 2030 at a CAGR of 5.8%, driven by rising prevalence of mental health disorders.
Read More
The Biotech Ingredient market size is expected to reach $87.06 billion in 2030 at a CAGR of 6.6%, driven by increasing demand for personal care products.
Read More
The Biotech Collaborations market size is expected to reach $159.77 billion in 2030 at a CAGR of 11.0%, driven by rising demand for personalized medicine.
Read More
The Biosimilars market size is expected to reach $48.52 billion in 2030 at a CAGR of 17.4%, driven by increasing healthcare expenditures worldwide.
Read More
The Biosimilar Therapeutic Peptides market size is expected to reach $6.11 billion in 2030 at a CAGR of 11.9%, driven by rising prevalence of chronic diseases.
Read More
The Biosimilar Monoclonal Antibodies market size is expected to reach $14.58 billion in 2030 at a CAGR of 6.6%, driven by growing autoimmune disease prevalence.
Read More
The Biosimilar Lymphocyte Modulator market size is expected to reach $3.53 billion in 2030 at a CAGR of 11.1%, driven by rising incidence of autoimmune disorders.
Read More